DaVita
DVA
#1731
Rank
A$17.51 B
Marketcap
A$272.81
Share price
-0.33%
Change (1 day)
25.30%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): A$16.39

According to DaVita's latest financial reports the company's current EPS (TTM) is A$15.40. In 2025 the company made an earnings per share (EPS) of A$14.16 a decrease over its 2024 EPS that were of A$15.44.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$16.3915.75%
2025A$14.16-8.25%
2024A$15.4444.94%
2023A$10.6527.26%
2022A$8.37-35.56%
2021A$12.9944.1%
2020A$9.0119.7%
2019A$7.53540.48%
2018A$1.18-76.07%
2017A$4.91-19.31%
2016A$6.09242.52%
2015A$1.78-62.87%
2014A$4.7913.43%
2013A$4.228.45%
2012A$3.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$34.02 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$15.90 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$27.22 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.70-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA